Nyrada Inc |
High $0.03 |
Low $0.03 |
Trades 20 |
Turnover $17,485 |
Volume 622,600 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (13-Nov) $133,825,608 (1,377th) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 622,600 |
Shortsold (6-Nov) 27,920 (0.01%) (580th) |
|
52w High $1.44 |
52w Low $0.390 |
P/E - |
EPS -0.03 |
Trading Halt
NYR released this announcement to the ASX on 29 January 2021, 9:13. The announcement is marked as price sensitive, and is 2 page(s) in length and 251.74kb in size.
You can view all announcements from NYR and see how they appear on a price chart on the announcements page.
At the date of this announcement, NYR was 0.001% short sold according to ASIC data. It was ranked the 633rd most shorted stock on the ASX. It is now ranked as the 580th most shorted stock on the ASX with 0.011% of total shares short sold as of the latest reported data (06 November 2026).
| Other Recent Announcements from NYR | |
|---|---|
| Cholesterol-Lowering Program Update | 26 June 2023, 9:55 |
| Brain Injury Program Preclinical Development Update | 9 June 2023, 8:18 |
| Cholesterol-Lowering Program Preclinical Studies Completed | 26 May 2023, 8:44 |
| Trading Halt | 29 January 2021, 9:13 |
| Nyrada Quarterly Activities Report & Appendix 4C | 28 January 2021, 8:29 |
| Nyrada Reports Further Results from Cholesterol Study | 25 January 2021, 8:22 |
| Unlisted Scientific Advisory Board Options Expiry 15 Feb 21 | 22 January 2021, 8:23 |
If you were already registered, log in here.